Variations in lipoprotein levels after myocardial infarction and unstable angina: The Latin trial

Italian Heart Journal

Volumn 3, Issue 10, 2002, Pages 587-592

  Fresco, Claudio ^a   Maggioni, Aldo P ^b   Signorini, Stefano ^c   Merlini, Piera A ^d   Mocarelli, Paolo ^c   Fabbri, Gianna ^b   Lucci, Donata ^b   Tubaro, Marco ^e   Gattone, Marinella ^a   Schweiger, Carlo ^f  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

^c DESIO HOSPITAL   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

^f Cardiac Rehabilitation Department   (Italy)

Author keywords

Cholesterol; Myocardial infarction; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; SYMPTOMATOLOGY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TRIGLYCERIDES;

EID: 12244249836     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ryder RE, Hayes TM, Mulligan IP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? BMJ 1984; 289: 1651-4.
2. Ahnve S, Angelin B, Edhag O, Berglund L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med 1989; 226: 297-301.
3. Carlsson R, Lindberg G, Westin L, Israelsson B. Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis. Br Heart J 1995; 74: 18-20.
4. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993; 22: 933-40.
5. Jacobs DR, Hebert B, Schreiner PJ, Sidney S, Iribarren C, Hulle S. Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 1997; 146: 558-64.
6. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
7. Sacks FM, Pfeffer MA, Moyè LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
8. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
9. Fattore L, Vetrano A, Melorio S, et al. Andamento del profilo lipidico plasmatico nelle sindromi coronariche acute. L'uso di fibrinolitici ed eparina non lo modificano significativamente. Ital Heart J Suppl 2000; 1: 1451-6.
10. Bremner WF, Sothern RB, Kanabrocki EL, et al. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 2000; 139: 164-73.
11. Grundy SM, Balady GJ, Criqui MH, et al. When to start cholesterol lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation 1997; 95: 1683-5.
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
13. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-8.
14. Aronow HD, Roe MT, Lauer MS, et al. Early and striking mortality reduction after acute coronary syndromes following lipid-lowering therapy. (abstr) J Am Coll Cardiol 2000; 35 (Suppl A): 411.
15. Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-6.